ALLO vs ORLY · rev $4.6M vs P/E 34, rev $9.45B
Allogene Therapeutics Inc (ALLO) versus O’Reilly Automotive Inc (ORLY) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Latest reported ALLO revenue for 2026-06-30 was $4.6M. Net income was -$85.3M. ALLO currently screens at market cap $258.1M.
Latest reported ORLY revenue for 2026-06-30 was $9.45B. Net income was $1.32B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
ALLO currently screens at market cap $258.1M. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Not investment advice. Open the ALLO and ORLY stock pages for the full models.
Not investment advice.